What are the consensus estimates for TRIB stock next earnings?
The consensus EPS estimate for the next earnings of TRINITY BIOTECH PLC-SPON ADR (TRIB) is -0.21 USD and the consensus revenue estimate is 17.34M USD.
TRINITY BIOTECH PLC-SPON ADR (TRIB) Forecast, Price Target & Analyst Ratings
NASDAQ:TRIB • US8964385046
Current stock price
0.605 USD
+0 (+0.13%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRINITY BIOTECH PLC-SPON ADR (TRIB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q3 / 2025
- EPS Estimate
- -$0.21
- Revenue Estimate
- 17.34M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.61 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
TRIB was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about TRIB.
In the previous month the buy percentage consensus was at a similar level.
TRIB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q3 / 2025
- EPS Estimate
- -$0.21
- Revenue Estimate
- 17.34M
- Revenue Q2Q
- 14.44%
- EPS Q2Q
- 53.43%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 62.521M -22.96% | 56.832M -9.10% | 61.555M 8.31% | 69.87M 13.51% | 79.05M 13.14% | |
| EBITDA YoY % growth | -11.184M -221.54% | -14.163M -26.64% | -14.193M -0.21% | N/A | N/A | |
| EBIT YoY % growth | -13.517M -309.31% | -15.94M -17.93% | -16.058M -0.74% | -6.114M 61.93% | 1.295M 121.18% | |
| Operating Margin | -21.62% | -28.05% | -26.09% | -8.75% | 1.64% | |
| EPS YoY % growth | -6.25 -366.41% | N/A 90.37% | -2.68 -346.00% | -0.92 65.80% | -0.50 45.56% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 53.43% | -0.17 84.79% | -0.19 32.14% | -0.11 54.17% | -0.14 33.33% | -0.05 70.59% |
| Revenue Q2Q % growth | 17.34M 14.44% | 18.36M 15.78% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.316M 48.56% | -510K 94.12% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TRINITY BIOTECH PLC-SPON ADR / TRIB Forecast FAQ
What is the consensus rating for TRIB stock?
The consensus rating for TRINITY BIOTECH PLC-SPON ADR (TRIB) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.